Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Handling of Exothermic Reactions – V 2.0

Posted on By

API Manufacturing: SOP for Handling of Exothermic Reactions – V 2.0

Standard Operating Procedure for Handling of Exothermic Reactions in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/024/2025
Supersedes SOP/API/024/2022
Page No. Page 1 of 11
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for the safe handling of exothermic reactions during API manufacturing, ensuring thermal control, process safety, and compliance with regulatory standards.

2. Scope

This SOP applies to all operations involving exothermic chemical reactions performed in reactors within the API manufacturing facility, including pilot and production-scale equipment.

3. Responsibilities

  • Production Operator: Execute the reaction according to the BMR and monitor temperature and pressure closely.
  • Process Engineer: Evaluate heat release data and define charging rate and safety controls.
  • QA Personnel: Ensure the process is performed in accordance with validated procedures and GMP compliance.
  • EHS Personnel: Provide risk mitigation tools and emergency response support.
See also  API Manufacturing: SOP for Environmental Monitoring in Warehouse - V 2.0

4. Accountability

The Production Head and EHS Head are accountable for ensuring process safety during exothermic reactions and prompt management of any deviations.

5. Procedure

5.1 Prerequisites and Controls

  1. Verify the BMR for:
    • Reaction enthalpy
    • Maximum temperature (Tmax)
    • Critical process parameters
  2. Ensure:
    • Reactor temperature probe is calibrated
    • Emergency cooling system is functional
    • Pressure relief valve is in place
    • Gas scrubber (if applicable) is operational
  3. Keep antifoaming and quenching agents ready at the site.

5.2 Charging Strategy for Exothermic Reactions

  1. Begin agitation and maintain initial temperature as per BMR.
  2. Use controlled or metered addition for critical reagents (e.g., acids, oxidizers).
  3. For manual additions, follow the “Split Charging” technique:
    • Add initial 5–10% of material and observe heat rise
    • Wait for stabilization and proceed in increments
  4. Record charging start and end time, rate, and interval in the “Exothermic Reaction Log” (Annexure-1).

5.3 Monitoring During Reaction

  1. Monitor:
    • Jacket and mass temperature
    • Pressure build-up
    • Foaming or gas evolution
  2. Use “Temperature-Time Profile Chart” for continuous trend plotting (Annexure-2).
  3. Do not exceed defined Tmax by more than 2°C; initiate hold or quenching if required.
See also  API Manufacturing: SOP for Monitoring of Reaction Parameters - V 2.0

5.4 Emergency Handling

  1. In case of temperature runaway:
    • Stop reagent addition
    • Initiate cooling via jacket/chiller
    • Add quenching agent (if validated)
    • Evacuate area if vapors evolve excessively
  2. Document deviation using the “Exothermic Incident Report Form” (Annexure-3).
  3. Restart batch only after QA and EHS approval.

5.5 Post-Reaction Documentation

  1. Ensure complete recording of:
    • All parameters monitored
    • Any deviation actions taken
    • Residual heat observed post-reaction
  2. Attach reactor trend reports (DCS or manual).
  3. Sign and archive records with batch documentation.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • EHS: Environment, Health & Safety
  • Tmax: Maximum Allowable Temperature

7. Documents

  1. Exothermic Reaction Log (Annexure-1)
  2. Temperature-Time Profile Chart (Annexure-2)
  3. Exothermic Incident Report Form (Annexure-3)

8. References

  • ICH Q9 – Quality Risk Management
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • 21 CFR Part 211.100 – Written procedures; deviations
See also  API Manufacturing: SOP for Disposal of Rejected or Contaminated Materials - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Exothermic Reaction Log

Date Batch No. Reagent Start Time End Time Rate Temp Range
13/04/2025 API-EX202504 H2SO4 09:00 09:45 10 mL/min 25–38°C

Annexure-2: Temperature-Time Profile Chart

Time Jacket Temp (°C) Mass Temp (°C) Pressure (bar) Operator
09:00 26 27.5 1.1
09:15 27 29.2 1.1

Annexure-3: Exothermic Incident Report Form

Date Batch No. Deviation Action Taken Reviewed By (QA)
13/04/2025 API-EX202504 Temp exceeded 42°C Hold added, cooling applied

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2022 1.0 Initial Release New SOP Creation QA Head
13/04/2025 2.0 Added Emergency Response Actions Process Safety Update QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: SOP for Proper Use of Storage Bin Systems for Raw Materials – V 2.0
Next Post: Creams: SOP for Operating Batch Mixers in Cream Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version